Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Research Project (R01)
Project #
1R01FD003870-01
Application #
7931714
Study Section
Special Emphasis Panel (ZFD1-SRC (99))
Project Start
2009-09-21
Project End
2011-08-31
Budget Start
2009-09-21
Budget End
2011-08-31
Support Year
1
Fiscal Year
2009
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
018571088
City
Boston
State
MA
Country
United States
Zip Code
02215
Secemsky, Eric A; Yeh, Robert W; Kereiakes, Dean J et al. (2017) Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study. JACC Cardiovasc Interv 10:942-954
Resor, Charles D; Nathan, Ashwin; Kereiakes, Dean J et al. (2016) Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study. Circulation 134:989-998
Meredith, Ian T; Tanguay, Jean-François; Kereiakes, Dean J et al. (2016) Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study. Circulation 133:1772-82
Mauri, Laura; Elmariah, Sammy; Yeh, Robert W et al. (2016) Causes of late mortality with dual antiplatelet therapy after coronary stents. Eur Heart J 37:378-85
Yeh, Robert W; Secemsky, Eric A; Kereiakes, Dean J et al. (2016) Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA 315:1735-49
Kereiakes, Dean J; Yeh, Robert W; Massaro, Joseph M et al. (2015) Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial. JAMA 313:1113-21
Yeh, Robert W; Kereiakes, Dean J; Steg, Philippe Gabriel et al. (2015) Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. J Am Coll Cardiol 65:2211-21
Yeh, Robert W; Czarny, Matthew J; Normand, Sharon-Lise T et al. (2015) Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes 8:96-102
Kereiakes, Dean J; Yeh, Robert W; Massaro, Joseph M et al. (2015) Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy. JACC Cardiovasc Interv 8:1552-62
Mauri, Laura; Kereiakes, Dean J; Yeh, Robert W et al. (2014) Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 371:2155-66

Showing the most recent 10 out of 11 publications